The Evolving Pharmaceutical Patent Landscape in the MENA Region
September 03, 2026
Thought Leadership
The Middle East and North Africa (MENA) regions have undergone a profound transformation over the past decade. Still regarded primarily as a market for imports, the region is increasingly becoming an innovation-driven ecosystem. The pharmaceutical sector is no exception to this evolving landscape. From a market for imported medicines and generic manufacturing, the industry is now characterized by expanding pharmaceutical manufacturing, stronger intellectual property (IP) frameworks, substantive patent examination, and growing investment in biotechnology and life sciences. Read more insights from Namir Sioufi, Partner and Regional Head of Patents at Saba IP.